Clinical Trial Update: Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid [NA]

View source ↗

Summary

Pilot study using Technetium-99m MIBI SPECT-CT imaging for papillary thyroid cancer; the update provides no results or phase information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Cancer

Drugs mentioned

• Technetium-99m MIBI (Sestamibi)

Snippet

Sponsor: Chulalongkorn University | Conditions: Papillary Thyroid Cancer | NA | Status: UNKNOWN